Liquid embolic agents for renal angiomyolipoma embolisation achieved the greatest tumour reduction with low re-intervention rates, while coil-only embolisation showed inferior outcomes.
Do liquid embolic agents improve tumour reduction and reduce re-intervention rates compared to coil-only embolisation in patients with renal angiomyolipoma?
Liquid embolic agents are superior to coil-only embolisation for achieving tumour reduction and minimizing re-intervention in the treatment of renal angiomyolipoma.
Absolute Event Rate: 0% vs 0%
SAE is a safe and effective treatment for r-AML in both elective and emergency settings. Liquid embolic agents achieved the greatest tumour reduction with low re-intervention rates, while coil-only embolisation showed inferior outcomes and should be avoided where possible.
O'Shea et al. (Wed,) reported a other. Liquid embolic agents for renal angiomyolipoma embolisation achieved the greatest tumour reduction with low re-intervention rates, while coil-only embolisation showed inferior outcomes.